Hepatitis B Infection 100% Eliminated With Cancer Drug Combination In Preclinical Model

A cancer drug was 100 percent successful in clearing away hepatitis B infections in preclinical models for an Australian study. If researchers successfully replicate the results in human clinical trials, the drug may become the first-ever cure to the hepatitis B virus and may serve as a model for treating other viruses, such as HIV and herpes.

Researchers at the Walter and Eliza Hall Institute in Melbourne, Australia used a combination of the cancer drug birinapant and the antiviral drug entecavir to completely eliminate hepatitis B infections in “hundreds of tests in preclinical models,” lead researcher Dr. Marc Pellegrini explained in a press release. Human trials began in December 2014, and drug testing has currently moved on to a phase 1/2a in clinical trials. 

Hepatitis B is a viral infection that attacks the liver. It is transmitted via contact with infected blood or bodily fluids and

... read more at: http://www.medicaldaily.com/hepatitis-b-infection-100-eliminated-cancer-drug-combination-preclinical-model-329938